Outcome of Board Meeting held today, i.e, on Wednesday, November 12 ,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adeshwar Meditex's board approved the unaudited financial results for the half-year ended September 30, 2025. Revenue from operations fell about 26% to Rs 3,005.78 lakhs compared to Rs 4,089.59 lakhs in the same period last year. Profit for the period dropped to Rs 73.10 lakhs from Rs 90.41 lakhs, and EPS slipped to Rs 0.51 from Rs 0.63. The board also noted the demise of Mr. Benegal Parameshwara Udpa, a Non-Executive Independent Director, and proposed appointing Mr. K. Raghupathi Bhat as a Non-Executive Director subject to regulatory approvals. Cash and cash equivalents at end of September plunged to just Rs 4.72 lakhs from Rs 203.86 lakhs as of March 2025, mainly due to large debt repayments.
Sharply lower revenue and weak cash position are red flags for shareholders, though reduced borrowings and stable margins offer some comfort. The independent director vacancy could raise near-term governance concerns until a replacement is formally inducted.